COCP News and Press, Cocrystal Pharma Inc. From 04/15/20

Obalon Therapeutics (NASDAQ: OBLN ) -25% . More news on: Obalon Therapeutics, Inc., NeuroMetrix, Inc., Cocrystal Pharma, Inc., Stocks on the move, , Read more ...

– Presentation with live audio webcast on Wednesday, April 22 at 11:00 AM ET, immediately followed by an interactive Q&A session – BOTHELL, WA,, April 15, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .  (NASDAQ: COCP), (“Cocrystal” or the...

Cocrystal Pharma (NASDAQ: COCP ) provides business outlook for 2020 and expected milestones. More news on: Cocrystal Pharma, Inc., Healthcare stocks news, Read more ...

Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Continuing collaboration with Merck to discover and develop certain proprietary influenza A/B antiviral agents Exp...

The deadly coronavirus is having a serious economic impact on the world and causing widespread panic. Major stock markets saw a much-needed uptick on Thursday, but it’s uncertain how long that will last. The Nasdaq, S&P 500 and the Dow Jones were all in the green on Thursday after ...

Amidst the deadly coronavirus outbreak, Wall Street suffered its biggest point drop in a single day on Monday and the Dow fell below 20,000 points at the end of Wednesday, nearly erasing all of the gains Trump has made during his presidency. Fed intervention has done little to stabilize marke...

Certain coronavirus plays are the lone beneficiaries, as usual, during the U.S. market's turmoil related to COVID-19. More news on: NanoViricides, Inc., Alpha Pro Tech, Ltd., AIM ImmunoTech Inc., Healthcare stocks news, Stocks on the move, Read more ...

The Coronavirus has now been declared a pandemic by the World Health Organization (WHO). Entire countries are being quarantined, many businesses worldwide are closing doors, airline flights are being restricted and even the National Guard has been called to aid in the fight against the corona...

BOTHELL, WA, March 11, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”) , a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today the closing of its previou...

BOTHELL, WA, March 09, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”) , a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that it has ente...